Atrial Fibrillation Trial, Recruiting (NCT05432024)

Atrial Fibrillation Trial, Recruiting NCT05432024 Sponsor: R&D Cardiologie Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT05432024 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (either episodes that come and go, or a more ongoing form), meeting specific diagnosis guidelines set by a major European heart organisation in 2020
People who are already scheduled to have a heart procedure called catheter ablation, using one of three specific techniques: high-power short-duration radiofrequency ablation, ultra-low temperature cryo ablation, or pulsed field ablation

Who may not be able to join:

People with a known or suspected allergic reaction to a substance called gadolinium (a dye sometimes used in medical scans)
People who are unable to have an MRI scan for any reason, such as claustrophobia (fear of enclosed spaces), certain medical implants or devices, or a body size that makes MRI scanning unsuitable (confirm with trial site)
People who are currently pregnant or breastfeeding
People who have previously had a procedure or surgery on the left side of their heart's upper chamber

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lucas VA Boersma, MD, PhD, St. Antonius Hospital

Phone: 0883200900

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05432024

Sponsor: R&D Cardiologie

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 0883200900

More information: https://clinicaltrials.gov/study/NCT05432024

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (either episodes that come and go, or a more ongoing form), meeting specific diagnosis guidelines set by a major European heart organisation in 2020
People who are already scheduled to have a heart procedure called catheter ablation, using one of three specific techniques: high-power short-duration radiofrequency ablation, ultra-low temperature cryo ablation, or pulsed field ablation

Who may not be able to join:

People with a known or suspected allergic reaction to a substance called gadolinium (a dye sometimes used in medical scans)
People who are unable to have an MRI scan for any reason, such as claustrophobia (fear of enclosed spaces), certain medical implants or devices, or a body size that makes MRI scanning unsuitable (confirm with trial site)
People who are currently pregnant or breastfeeding
People who have previously had a procedure or surgery on the left side of their heart's upper chamber

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

R&D Cardiologie

Registry

ClinicalTrials.gov

Start date

8 March 2023

Est. completion

1 April 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Length of gaps in the ablation lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov